SGHT Q3 2023 Earnings — Sight Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SGHTSight Sciences, Inc.

$224M

Q3 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$20M+7.1% YoY

Gross Profit

$17M86.6% margin

Operating Income

-$13M-67.0% margin

Net Income

-$13M-65.1% margin

EPS (Diluted)

$-0.27

QoQ Revenue Growth

-14.8%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$177M

Total Liabilities

$50M

Stockholders' Equity

$127M

Cash & Equivalents

$145M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$20M	$19M	+7.1%
Gross Profit	$17M	$16M	+10.1%
Operating Income	-$13M	-$22M	+38.6%
Net Income	-$13M	-$22M	+41.4%

Revenue Segments

Surgical Glaucoma

$18M92%

Dry Eye

$2M8%